Low-level HIV infection of hepatocytes

Virology Journal

Volumn 9, Issue , 2012, Pages

  Kong, Ling ^a   Maya, Walter Cardona ^a,b   Moreno Fernandez, Maria E ^c   Ma, Gang ^a   Shata, Mohamed T ^a   Sherman, Kenneth E ^a   Chougnet, Claire ^c   Blackard, Jason T ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Hepatocyte; HIV; Huh7.5; Integration; Liver

Indexed keywords

GAG PROTEIN; RALTEGRAVIR; VIRUS DNA;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CELL; LYMPHOCYTE; NONHUMAN; PROTEIN EXPRESSION; SUPERNATANT; VIRUS REPLICATION;

CELL LINE; HEPATOCYTES; HIV INFECTIONS; HIV-1; HUMANS; VIRUS REPLICATION;

EID: 84864700529     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-157     Document Type: Article

References (54)

1. Hepatobiliary and pancreatic infections in AIDS: Part one. Keaveny AP, Karasik M, AIDS Patient Care and STDs 1998 12 5 347 357 10.1089/apc.1998.12.347 11361970 (Pubitemid 28243704)
2. Acute human immunodeficiency virus type 1 infection. Kahn JO, Walker B, N Engl J Med 1998 339 1 33 39 10.1056/NEJM199807023390107 9647878
3. Hepatobiliary complications in patients with human immunodeficiency virus infection. Bonacini M, Am J Med 1992 92 404 411 10.1016/0002-9343(92)90271-C 1558086
4. Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy. Ingiliz P, et al. Hepatology 2009 49 2 436 442 10.1002/hep.22665 19085967
5. Pathology of AIDS-related liver disease. Lefkowitch J, Dig Dis 1994 12 6 321 330 10.1159/000171468 7712615
6. Impact of highly active antiretroviral therapy on the spectrum of liver disease in HCV-HIV coinfection. Sterling R, et al. Clin Gastroenterol Hepatol 2004 2 5 432 439 10.1016/S1542-3565(04)00129-6 15118983 (Pubitemid 38561242)
7. Correlation between HIV viral and aminotransferases as liver damage markers in HIV infected naive patients: a concordance cross-sectional study. Mata-Marin JA, et al. Virol J 2009 6 181 10.1186/1743-422X-6-181 19878552
8. HIV mono-infection is associated with FIB-4-a noninvasive index of liver fibrosis-in women. Blackard JT, et al. Clin Infect Dis 2011 52 5 674 680 10.1093/cid/ciq199 21248367
9. HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver? Blackard JT, Sherman K, Journal of Viral Hepatitis 2008 15 5 323 330 10.1111/j.1365-2893.2008.00970.x 18208497 (Pubitemid 351473633)
10. Epidemiology of hepatitis C virus infection. Alter M, World J Gastroenterol 2007 13 17 2436 2441 17552026 (Pubitemid 46929498)
11. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Tedaldi E, et al. Clin Infect Dis 2003 36 363 367 10.1086/345953 12539079 (Pubitemid 36169673)
12. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Bica I, et al. Clin Infect Dis 2001 32 492 497 10.1086/318501 11170959 (Pubitemid 32173638)
13. Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. Salmon-Ceron D, et al. Journal of Hepatolology 2005 42 6 799 805 10.1016/j.jhep.2005.01.022 (Pubitemid 40693195)
14. HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies. Operskalski EA, Kovacs A, Current HIV/AIDS Reports 2011 8 1 12 22 10.1007/s11904-010-0071-3 21221855
15. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Wakita T, et al. Nature Medicine 2005 11 7 791 796 10.1038/nm1268 15951748 (Pubitemid 41021213)
16. Robust hepatitis C virus infection in vitro. Zhong J, et al. Proc Natl Acad Sci 2005 102 26 9294 9299 10.1073/pnas.0503596102 15939869 (Pubitemid 40923557)
17. An in vitro model of hepatitis C virion production. Heller T, et al. Proc Natl Acad Sci 2005 102 7 2579 2583 10.1073/pnas.0409666102 15701697 (Pubitemid 40279419)
18. Complete replication of hepatitis C virus in cell culture. Lindenbach B, et al. Science 2005 309 5734 623 626 10.1126/science.1114016 15947137 (Pubitemid 41033648)
19. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. Blight KJ, McKeating JA, Rice C, J Virol 2002 76 24 13001 13014 10.1128/JVI.76.24.13001-13014.2002 12438626 (Pubitemid 35386984)
20. Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells. Cai Z, et al. J Virol 2005 79 22 13963 13973 10.1128/JVI.79.22.13963-13973.2005 16254332 (Pubitemid 41552695)
21. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophage tropic isolates of human immunodeficiency virus type 1. Platt EJ, et al. J Virol 1998 72 4 2855 2864 9525605 (Pubitemid 28175522)
22. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. Adachi A, et al. J Virol 1986 59 2 284 291 3016298 (Pubitemid 16013975)
23. A novel strategy for constructing clustered point mutations. Haltiner M, Kempe T, Tjian R, Nucleic Acids Res 1985 13 3 1015 1025 10.1093/nar/13.3.1015 2987803
24. Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. Rossio JL, et al. J Virol 1998 72 10 7992 8001 9733838 (Pubitemid 28421792)
25. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. Kimpton J, Emerman M, J Virol 1992 66 4 2232 2239 1548759
26. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Chomont N, et al. Nature Medicine 2009 15 8 893 900 10.1038/nm.1972 19543283
27. Human regulatory T cells are targets for human immunodeficiency virus (HIV) infection, and their susceptibility differs depending on the HIV type 1 strain. Moreno-Fernandez ME, et al. J Virol 2009 83 24 12925 12933 10.1128/JVI.01352-09 19828616
28. Identification and quantitation of HIV-1 in the liver of patients with AIDS. Cao YZ, et al. AIDS 1992 6 1 65 70 10.1097/00002030-199201000-00008 1543567
29. Redistribution of HIV outside the lymphoid system with onset of AIDS. Donaldson YK, et al. Lancet 1994 343 8894 383 385 7905551
30. HIV variability in the liver and evidence of possible compartmentalization. Blackard JT, et al. AIDS Research and Human Retroviruses 2011 27 10 1117 1126 10.1089/aid.2010.0329 21417757
31. Detection of HIV1 RNA and p24 antigen in HIV-1-infected human liver. Housset C, Lamas E, Brechot C, Res Virol 1990 141 2 153 159 10.1016/0923- 2516(90)90017-D 1971728 (Pubitemid 20147082)
32. Presence of HIV-1 in human parenchymal and non-parenchymal liver cells in vivo. Housset C, et al. J Hepatol 1993 19 2 252 256 10.1016/S0168-8278(05) 80579-3 8301058 (Pubitemid 23363032)
33. Immunohistochemical studies of human immunodeficiency virus-1 in liver tissues of patients with AIDS. Hoda SA, White JE, Gerber M, Mod Pathol 1991 4 5 578 581 1758870
34. A pathological study on liver tissues of patients with HIV infection. Lang ZW, et al. Zhonghua Gan Zang Bing Za Zhi 2005 13 12 930 932 16381643
35. Immunohistochemical evidence for HIV-1 infection in the liver of HIV-infected patients. Jiang TJ, et al. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2005 19 2 152 154 16027784
36. TAR- and Tat-independent replication of human immunodeficiency virus type 1 in human hepatoma cells. Zhu M, Duan L, Pomerantz R, AIDS Research and Human Retroviruses 1996 12 12 1093 1101 10.1089/aid.1996.12.1093 8844014 (Pubitemid 26317413)
37. Identification of a human immunodeficiency virus type 1 TAR binding protein in human hepatoblastoma HepG2 cells that trans-activates HIV-1 LTR-directed gene expression. Pizzella T, Banerjee R, DNA Cell Biology 1994 13 1 67 74 10.1089/dna.1994.13.67 (Pubitemid 2044235)
38. Cytokine regulation of HIV-1 LTR transactivation in human hepatocellular carcinoma cell lines. Hsu ML, et al. Cancer Lett 1995 94 1 41 48 10.1016/0304-3835(95)03820-M 7621443
39. Human immunodeficiency virus-induced apoptosis of human hepatocytes via CXCR4. Vlahakis S, et al. J Infect Dis 2003 188 1455 1460 10.1086/379738 14624370 (Pubitemid 37523930)
40. Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism. Munshi N, et al. J Infect Dis 2003 188 1192 1204 10.1086/378643 14551890 (Pubitemid 37338984)
41. Molecular mechanism of hepatic injury in coinfection with hepatitis C virus and HIV. Balasubramanian A, et al. Clin Infect Dis 2005 41 Suppl 1 32 S37 16265611
42. HCV and HIV envelope proteins collaboratively mediate IL-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes. Balasubramanian A, Ganju R, Groopman J, J Biol Chem 2003 278 37 35755 35766 10.1074/jbc.M302889200 12824191 (Pubitemid 37102352)
43. Elevated levels of interleukin-8 in serum are associated with hepatitis C infection and resistance to interferon therapy. Polyak S, et al. J Virol 2001 75 13 6209 6211 10.1128/JVI.75.13.6209-6211.2001 11390624 (Pubitemid 32553153)
44. Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. Polyak S, et al. J Virol 2001 75 13 6095 6106 10.1128/JVI.75.13.6095-6106.2001 11390611 (Pubitemid 32553140)
45. The alpha chemokine, interleukin 8, inhibits the antiviral action of interferon a. Khabar K, et al. Journal of Experimental Medicine 1997 186 7 1077 1085 10.1084/jem.186.7.1077 9314556 (Pubitemid 27441151)
46. CD4-independent, productive human immunodeficiency virus type 1 infection of hepatoma cell lines in vitro. Cao YZ, et al. J Virol 1990 64 6 2553 2559 2159530
47. Inhibition of HIV-1 productive infection in hepatoblastoma HepG2 cells by recombinant tumor necrosis factor-a. Banerjee R, et al. AIDS 1992 6 10 1127 1131 10.1097/00002030-199210000-00010 1466843
48. Characterization of a CD4-independent clinical HIV-1 that can efficiently infect human hepatocytes through chemokine (C-X-C motif) receptor 4. Xiao P, et al. AIDS 2008 22 14 1749 1757 10.1097/QAD.0b013e328308937c 18753859
49. Human hepatoma cells transmit surface bound HIV-1 to CD4+ T cells through an ICAM-1/LFA-1-dependent mechanism. Fromentin R, MR T, Tremblay M, Virology 2010 398 168 175 10.1016/j.virol.2009.12.008 20034651
50. Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigen. Iser DM, et al. J Virol 2010 84 12 5860 5867 10.1128/JVI.02594-09 20357083
51. CD81 expression is important for the permissiveness of Huh7 cell clones for heterogeneous hepatitis C virus infection. Akazawa D, et al. J Virol 2007 81 10 5036 5045 10.1128/JVI.01573-06 17329343 (Pubitemid 46744415)
52. Infectious HIV increases hepatitis C virus (HCV) expression in hepatocytes. Kong L, Welge JA, Blackard J, 18th Conference on Retroviruses and Opportunistic Infections MA: Boston 2011
53. Immunological dynamics in hemophiliac patients infected with hepatitis C and human immunodeficiency virus: influence of antiretroviral therapy. Yokozaki S, et al. Blood 2000 96 13 4293 4299 11110704
54. Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters. Beld M, et al. Virology 1998 244 504 512 10.1006/viro.1998.9130 9601518 (Pubitemid 28384112)